XML 27 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity Incentive Plans
3 Months Ended
Mar. 31, 2012
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Note 6 – Equity Incentive Plans

 

General

 

DCT’s share-based awards are long-term retention plans that are intended to attract, retain and provide incentives for talented employees. DCT believes its share-based awards are critical to its operation and productivity. The employee share-based award plans allow DCT to grant, on a discretionary basis, incentive stock options and non-qualified stock options.

 

The following table sets forth, by the respective option plan, certain aspects of DCT’s stock options as of March 31, 2012:

 

    Option Approval Method     Options Outstanding and Options Available  
Description   Board of
Directors
    Board of
Directors 
and
Shareholders
    Total     Outstanding     Available
For
Future
Grant
    Total  
2002 Amended and Restated Stock Option Plan           3,200,000       3,200,000       2,478,710       721,290       3,200,000  
2006 Stock Option Plan           2,500,000       2,500,000       2,299,000       201,000       2,500,000  
2009 Stock Option Plan           1,500,000       1,500,000       1,179,333       320,667       1,500,000  
2010 Stock Option Plan           3,500,000       3,500,000       2,500,000       1,000,000       3,500,000  
Key Personnel Option Grants     7,875,000             7,875,000       5,917,315             5,917,315  
      7,875,000       10,700,000       18,575,000       14,374,358       2,242,957       16,617,315  

 

Stock Options

 

DCT issues options under four different stock option plans as well as through employment agreements with key employees, executives and consultants (approved by the board of directors on a case-by-case basis).  Options generally vest over two to three years from the date of grant and expire seven to ten years from the date of grant.

 

Stock-Based Compensation

 

The following table sets forth the total stock-based compensation expense included in DCT’s Statements of Operations (in thousands):

 

    Three Months Ended
March 31,
 
    2012     2011  
Selling, general and administrative   $ 233     $ 291  
Research and development     14       31  
    $ 247     $ 322  

 

 

At March 31, 2012, DCT had approximately $692,000 of total unrecognized compensation cost related to unvested stock options. This cost is expected to be recognized over a weighted-average period of approximately one year.

 

Stock Option Activity and Outstanding

 

DCT had the following stock option activity during the three months ended March 31, 2012:

 

    Options     Weighted-
Average
Exercise
Price
 
Outstanding at December 31, 2011     14,524,358     $ 0.34  
Granted     -       -  
Cancelled     50,000       0.32  
Exercised     100,000       0.01  
Outstanding at March 31, 2012     14,374,358     $ 0.35  
Vested or expected to vest at March 31, 2012     14,374,358     $ 0.35  

 

The following table summarizes all options outstanding and exercisable by price range as of March 31, 2012:

 

      Options Outstanding     Options Exercisable  

 

 

Range of 
Exercise Prices

   

 

 

Number

Outstanding

    Weighted-
Average
Remaining
Contractual
Life (Years)
   

 

Weighted-

Average

Exercise
Price

   

 

 

Number

Exercisable

   

 

Weighted-
Average

Exercise
Price

 
                                 
$ 0.01       2,042,315       0.1     $ 0.01       2,042,315     $ 0.01  
$ 0.29-$0.45       9,432,043       5.9     $ 0.32       5,884,214     $ 0.32  
$ 0.60 - $0.70       2,900,000       6.6     $ 0.68       2,200,000     $ 0.68  
          14,374,358                       10,126,529          

 

The “intrinsic value” of options is the excess of the value of DCT stock over the exercise price of such options. The total intrinsic value of options outstanding (of which all are expected to vest) at March 31, 2012 was approximately $1,081,000. The total intrinsic value of options outstanding at December 31, 2011 was $1,546,000. The total intrinsic value for exercisable options was $953,000 and $1,303,000 at March 31, 2012 and December 31, 2011, respectively. The total intrinsic value was $27,000 for options exercised during the three months ended March 31, 2012.